LCTX Competitors & Alternatives
Compare Lineage Cell Therapeutics Inc with similar stocks in the same industry
Biotechnology
LCTX
Main Stock$1.11
Tradestie Score
45
Market Cap
$385.92M
Revenue Growth
-0.6%
Analyst Upside
+395.5%
Top Competitors
243 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.16
|
$319.22M | - | 38 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$17.05
|
$308.74M | - | 33 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$13.07
|
$304.12M | - | 39 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$20.84
|
$297.23M | - | 43 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$35.62
|
$293.03M | - | 50 | Compare |
|
OMER
Omeros Corporation
|
$18.61
|
$281.75M | 11.7 | 38 | Compare |
|
DBVT
DBV Technologies S.A.
|
$13.54
|
$275.54M | - | 41 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.02
|
$275.13M | - | 44 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$22.65
|
$269.08M | 0.1 | 51 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.72
|
$262.67M | - | 51 | Compare |
More LCTX Analysis
Data updated: Aug 29, 2026 | Industry: Biotechnology (SIC 2836)
243 stocks in this industry